SNNA stock forecast
Our latest prediction for Sienna Biopharmaceuticals, Inc.'s stock price was made on the Aug. 1, 2017 when the stock price was at 20.69$.
In the short term (2weeks), SNNA's stock price should outperform the market by 2.17%. During that period the price should oscillate between -3.28% and +5.31%.
In the medium term (3months), SNNA's stock price should outperform the market by 6.03%. During that period the price should oscillate between -6.25% and +16.43%.Get email alerts
About Sienna Biopharmaceuticals, Inc.
Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, clinical development, and commercialization of aesthetics and medical dermatology. Its products include Topical by Design platform for patients with inflammatory skin diseases and other dermatologic and aesthetic conditions through SNA-120, SNA-125, and SNA-001. The company was founded by Todd Harris and Frederick C. Beddingfield III on July 27, 2010 and is headquartered in Westlake Village, CA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -1.54$ per share.
The book value per share is 2.67$
Three months stock forecastAug. 1, 2017
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|